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background: Both obstructive sleep apnea (OSA) and 
prolonged QRS duration are associated with hypertension, 
heart failure, and sudden cardiac death. However, pos-
sible links between QRS duration and OSA have not been 
explored.
Methods: Cross-sectional study of 221 patients who under-
went polysomnography at our center. Demographics, cardio-
vascular risk factors and ECG were collected to explore a rela-
tionship between OSA and QRS duration.
Results: The apnea-hypopnea index (AHI) was positively 
correlated with QRS duration (r = 0.141, p = 0.03). Patients 
were divided into 3 groups: AHI < 5 (61), AHI 5-29 (104), and 
AHI > 30 (55). The mean QRS duration prolonged signifi cantly 
as OSA worsened (AHI < 5, 85 ± 9.5; AHI 5-29, 89 ± 11.9; 
and AHI > 30, 95 ± 19.9 ms, p = 0.001). QRS ≥ 100 ms was 
present in 12.7% of patients with severe OSA compared with 
0% in the rest of the sample (p < 0.0001). After adjustment 
for age, race, and cardiovascular risk factors, this association 
remained signifi cant in women but not in men.
Conclusion: QRS duration and OSA were signifi cantly associ-
ated. Severity of OSA independently predicted prolonged QRS 
in women but not men. Nevertheless, prolongation of QRS du-
ration in either sex may potentiate arrhythmic risks associated 
with OSA.
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Obstructive sleep apnea (OSA) has been associated with several cardiovascular conditions1,2 including hyperten-
sion,3 congestive heart failure,4 and sudden cardiac death.5 In 
fact, OSA has been associated with a 60% to 70% increased risk 
of cardiovascular morbidity and mortality.6
OSA is highly prevalent and underdiagnosed7 in the general 
population. This problem may be worse in subjects with coro-
nary artery disease, as recent studies have shown a 50% to 70% 
prevalence of OSA in such patients.7,8 This high prevalence 
suggests that OSA may play a key role in the development of 
cardiovascular events.
Numerous studies have shown that OSA is associated 
with changes in cardiac structure, including left ventricular 
hypertrophy,9-12which can widen the QRS complex on the elec-
trocardiogram (ECG).13 QRS duration is an independent predic-
tor of sudden cardiac death15,16 and mortality16,17 in conditions 
commonly associated with OSA, such as hypertension and 
heart failure. However, the relationship between OSA and QRS 
duration is unknown.
In this study we hypothesized that OSA severity, measured 
by the apnea-hypopnea index (AHI), is independently associ-
ated with QRS prolongation. If so, this could help explain any 
increased risk of sudden cardiac death in OSA.
METHODS
We conducted a retrospective cross-sectional study of con-
secutive patients who had a clinically indicated polysomno-
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gram (PSG) study from January 2007 through July 2009 at 
Albert Einstein Medical Center, Philadelphia, PA. Inclusion 
criteria were age over 18 years and availability of a resting 12-
lead ECG within the 6 months preceding polysomnography. 
Patients with known sleep apnea were excluded as were those 
with classic right or left bundle branch block or a ventricular 
paced rhythm. Patients with atrial fi brillation were included but 
other non-sinus rhythms were excluded. The fi nal study popula-
tion consisted of 221 subjects. This study was approved by the 
Albert Einstein Institutional Review Board.
Polysomnogram
All patients were initially evaluated by a certifi ed sleep 
medicine certifi ed physician. PSG recording and scoring were 
performed using the VIASYS SomnoStar Pro System. Electro-
encephalogram, electro-oculogram, and electromyogram were 
monitored for sleep staging. Nasal pressure monitoring, chest 
bRIEF SUMMARY
Current Knowledge/Study Rationale: QRS duration is an indepen-
dent predictor of mortality. Obstructive sleep apnea produces structural 
changes of the heart which can lead to a widened QRS but this potential 
association has not been adequately explored.
Study Impact: QRS duration prolonged signifi cantly as sleep apnea se-
verity increased; however, on multivariate analysis the effect remained 
signifi cant only in women. QRS widening could help explain associa-
tions between sleep apnea and cardiovascular events while the effect in 
women points to possible areas for future research.
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wall movement, abdominal movement, snoring, and oxygen 
saturation were monitored for respiratory assessment. Electro-
cardiogram and tibial electromyogram were monitored for car-
diac arrhythmias and nocturnal limb movements, respectively. 
The AHI, defined as the sum of apneas and hypopneas per hour 
of sleep, was recorded from the PSG report. OSA severity was 
defined by AHI according to recommendations from the Sleep 
Task Force of the American Academy of Sleep Medicine (no 
OSA when AHI < 5, mild-moderate OSA with AHI 5-30, and 
severe OSA with AHI > 30).17
Electrocardiogram
The resting 12-lead ECGs of these patients were accessed 
from their electronic medical records. Heart rate, QRS du-
ration, PR interval, and corrected QT interval (QTc) were 
abstracted from the computerized ECG interpretation (Mar-
quette 12SL ECG Analysis Program run on the MUSE ECG 
system). The onset of QRS is detected first because it is the 
easiest; the slope change is usually very rapid and in great 
contrast to the other slopes in the median. This is followed by 
QRS offset. The onsets and offsets are determined by an anal-
ysis of simultaneous slopes in all 12 leads. Onsets are defined 
as the earliest deflection in any lead, and offsets as the latest 
deflection in any lead. Thus, the QRS duration is measured 
from the earliest onset in any lead to the latest deflection in 
any lead. Similarly, the QT interval is measured from the ear-
liest detection of depolarization in any lead to the latest detec-
tion of repolarization in any lead. The PR interval is measured 
form the earliest detection of atrial depolarization in any lead 
to the earliest detection of ventricular depolarization in any 
lead (the QRS onset). The QT is corrected for heart rate using 
Bazett’s formula. The values of these intervals were recorded 
in milliseconds (ms).
Data Collection and Cardiovascular Risk Factors
PSG, ECG, and demographic data including age, gender, and 
race were collected from electronic medical records. Cardio-
vascular risk factors—namely hypertension, diabetes, coronary 
artery disease, congestive heart failure, atrial fibrillation, obe-
sity (BMI ≥ 30 kg/m2), and smoking status—were noted from 
the records. Recording of these variables were done blinded to 
the OSA status or severity.
Statistical Methods
Data were summarized by calculating mean ± SD for con-
tinuous variables, and numbers and percentages for categori-
cal variables. Due to non-linearity of the variables analyzed we 
used Spearman correlation coefficients to explore the associa-
tion as continuous variables between AHI, mean and minimum 
oxygen saturation during sleep, with QRS and other ECG inter-
vals. We performed one-way ANOVA and independent t-tests 
to assess differences between cardiovascular risk factors and 
ECG intervals by presence or absence of OSA and by its sever-
ity (AHI < 5; no OSA, AHI 5-29; mild-to-moderate OSA and 
AHI ≥ 30; severe OSA) and by mean oxygen saturation < 88 
% (cut-off used by Medicare for home oxygen) and minimum 
oxygen saturation < 94% (lowest quartile) during sleep. We 
then assessed whether severity of OSA was associated with a 
prolonged QRS (≥ 100 ms). Finally, we performed regression 
analyses to identify significant univariate predictors for QRS 
duration (p-value ≤ 0.10). To assess the independent effect of 
OSA on AHI and mean and minimum oxygen saturation during 
sleep, we performed multivariate analyses adjusting for age, 
sex, and cardiovascular risk factors (p-value < 0.05). Due to 
significant differences in QRS duration between men and wom-
en previously reported18,19 and noted in our study, we performed 
analyses stratified by gender, and therefore no adjustment for 
gender was needed. All analyses were performed using JMP 
8.0 (SAS Institute; Cary, NC) and 2-tailed p values < 0.05 were 
considered significant in advance.
RESULTS
Baseline characteristics of the 221 participants (64.2% fe-
male) are shown in Table 1. Characteristics of the subjects and 
prevalence of cardiovascular risk factors according to the pres-
ence or absence of OSA and its severity are shown in Table 2. 
Overall, subjects with OSA tended to be older and male. Sub-
jects with mild to moderate OSA had a higher prevalence of 
congestive heart failure and subjects with severe OSA tended to 
be more obese and hypertensive. Because there were no signifi-
cant differences between the mild and moderate OSA groups, 
we decided to cluster them in a single group.
QRS and AHI showed a weak but significant and positive 
correlation (rho = 0.14, p = 0.03). Table 3 displays ECG inter-
vals by presence or absence of OSA and by its severity. QRS 
was significantly wider as OSA severity increased (Figure 1). 
Furthermore, QRS ≥ 100 ms was present in 12.7% of those with 
severe OSA compared with 0% of patients in the mild to mod-
erate OSA group, and 0% in those without OSA, p < 0.0001 
(Figure 2). PR and QTc intervals were not significantly corre-
lated with AHI (rho = -0.03, p = 0.58 and rho = -0.02, p = 0.75, 
respectively) and were not significantly different among groups.
Table 1—Baseline characteristics of the subjects included 
in the study
Variable n = 221 Mean ± SD or Number (%)
Age 51.9 ± 13.8
Gender (Female) 142 (64.2)
Race
Caucasian 29 (13.1)
African American 170 (77)
Hispanic 19 (8.6)
Other (Asian) 3 (1.3)
No Obstructive sleep apnea 61 (27.6)
Obstructive sleep apnea 160 (72.3)
Mild-moderate 105 (47.5)
Severe 55 (24.8)
Obese (BMI > 30 kg/m2) 187 (85)
Smoking 77 (34.8)
Diabetes mellitus type 2 75 (33.9)
Hypertension 140 (63.3)
Coronary artery disease 34 (15.3)
Congestive heart failure 19 (8.6)
Atrial fibrillation 8 (3.6)
SD, standard deviation; BMI, body mass index.
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To examine a possible relationship between nocturnal hy-
poxemia and QRS duration, we also looked at mean oxygen 
saturation and minimal oxygen saturation. Mean QRS dura-
tion was 93.4 ± 16.4 ms for the lowest quartile of mean oxygen 
saturation (< 94%) versus 88.9 ± 14.3 ms for those with mean 
oxygen saturation ≥ 94% (p = 0.049). We next divided patients 
into those with minimum oxygen saturation of ≤ 88% (cur-
rent Medicare criteria for home oxygen prescription) and those 
with minimum oxygen saturation > 88%. Mean QRS duration 
for patients with nocturnal hypoxemia as defined above was 
91.6 ± 16.0 ms compared to 86.1 ± 10.3 ms for those without 
(p = 0.005). After stratifying by sex, the difference in QRS du-
ration remained significant in women (88.6 ± 14.3 ms vs. 83.5 ± 
8.3 ms in patients with and without nocturnal hypoxemia), but 
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Figure 2—QRS > 100 ms by presence or absence of OSA 
and by its severity
Table 2—Characteristics by presence or absence of obstructive sleep apnea and by its severity
Variable No OSA (n = 61) Mild-moderate OSA (n = 105) Severe OSA (n = 54) p-value
Age 47.3 ± 14.3 54.2 ± 11.5# 52.9 ± 16.1+& 0.0900
Sex (female) 50 (81.9) 63 (60)* 29 (52.7)^ 0.0020
Race
Caucasian 7 (11.5) 15 (14.3) 7 (12.7)
African American 45 (73.7) 79 (75.2) 46 (83.6)
Hispanic 8 (13.1) 10 (9.5) 1 (1.8)
Other (Asian) 1 (1.64) 1 (0.95) 1 (1.8) 0.51
Obese (BMI > 30 kg/m2) 48 (78.7) 90 (85.7) 49 (90.7)& 0.1800
Smoker 23 (37.7) 35 (33.3) 19 (34.5) 0.8400
Diabetes mellitus type 2 19 (31.1) 34 (32.4) 22 (40) 0.5400
Hypertension 34 (55.7) 67 (63.8) 39 (70.9)& 0.2300
Coronary artery disease 8 (13.1) 20 (19) 6 (10.9) 0.3300
Congestive heart Failure 2 (3.3) 12 (11.4)# 5 (9.1) 0.1900
Atrial fibrillation 1 (1.6) 3 (2.8) 4 (7.2) 0.2200
*p-value ≤ 0.05 for no OSA vs. mild-moderate OSA, #p-value ≤ 0.001 for no OSA vs. mild-moderate OSA, &p-value ≤ 0.07 for no OSA vs. severe OSA, 
+p-value ≤ 0.05 for moderate vs. severe OSA, ^p-value ≤ 0.001 for no OSA vs. severe OSA. BMI, body mass index.
Table 3—ECG intervals by presence or absence of OSA and by its severity
Variable No OSA (n = 61) Mild-moderate OSA (n = 105) Severe OSA (n = 54) p-value
PR interval 159.01 ± 26.7 163.09 ± 24.9 158.23 ± 27.2 0.4500
QRS interval 85.80 ± 9.5 89.19 ± 11.9* 95.20 ± 19.9^ 0.0014
QT interval 386.01 ± 39.8 390.30 ± 35.43 390.47 ± 42.4 0.7500
*p-value 0.01 for no OSA vs. mild-moderate OSA, ^p-value 0.0003 for no OSA vs. severe OSA. ECG, electrocardiogram; OSA, obstructive sleep apnea.
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Figure 1—QRS duration by obstructive sleep apnea severity 
measured by apnea-hypopnea index
0 = No OSA; 1 = Mild-moderate OSA; 2 = Severe OSA.
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not in men (96.1 ± 17.5 ms vs. 96.4 ± 11.5 ms in patients with 
and without nocturnal hypoxemia).
Sex, race, hypertension, coronary artery disease, congestive 
heart failure, and AHI were significant univariate predictors 
for QRS duration (Table 4). After stratifying by sex, women 
had a shorter QRS duration than men (86.8 ± 12.7 vs. 94.9 ± 
15.1 ms), consistent with previous studies.18,19 In multivariate 
analyses, in men, atrial fibrillation, congestive heart failure, and 
race remained significant predictors of QRS duration after ad-
justments, while in women, atrial fibrillation, congestive heart 
failure, and AHI remained as significant predictors (Table 5). 
Minimal oxygen saturation was not a significant predictor of 
QRS duration on multivariate analyses.
DISCUSSION
Our major finding is that QRS duration and OSA are signifi-
cantly associated. This was particularly true for patients with 
severe OSA (AHI > 30), where 12.7% had a QRS ≥ 100 ms 
compared to 0% of patients without OSA or with only mild to 
moderate OSA. After multivariate analyses, AHI remained a sig-
nificant predictor of prolonged QRS in women but not in men.
Previous Studies
Previous small studies have looked for a possible association 
between QRS duration and OSA. Andreas et al.20 found a mean 
QRS duration of 96 ± 9 ms in OSA, similar to the 95.20 ± 19.9 
ms found in our study. Their control subjects had similar QRS 
duration (96 ± 10 ms) and the authors concluded that OSA was 
not associated with QRS prolongation. In our study, subjects 
without OSA had a more normal QRS duration (85.8 ± 9.5 ms). 
This difference may relate to the fact that their controls were 
snorers with an AHI up to 10, while in our study controls had 
an AHI < 5 as suggested by the American Academy of Sleep 
Medicine Task Force.17 Furthermore, their sample size was 
small (n = 47). In another study, Steiner et al.21 studied 12 pa-
tients with congestive heart failure and compared ECG param-
eters by presence or absence of OSA. Although they noted no 
statistically significant changes in QRS duration between OSA 
groups, the mean QRS was 99 ± 13 ms in controls and 144 ± 43 
ms in patients with OSA. This study is limited by small sample 
size (6 patients in each group) and by the mean AHI of the OSA 
group being only 17.8; therefore few conclusions can be drawn 
from these results.
In previous studies, QRS ≥ 120 ms has been independently 
associated with all-cause mortality15,16 and sudden death.14-16 
Though mean QRS duration in our patients with severe OSA 
was < 120 ms, it is notable that only severe OSA subjects had a 
QRS ≥ 100 ms while this finding was absent in others. We can 
speculate that changes in QRS duration occur slowly and move 
in only one direction (wider). In addition OSA probably wors-
ens over time. Therefore our patients might, over time, develop 
additional QRS widening. Further study is needed to investi-
gate this possibility.
One of the interesting findings in this study is that AHI was 
independently associated with QRS duration in women but not 
in men. There are several possible ways to explain this. Prior 
studies have noted shorter QRS duration in women, as we also 
found. Any increase in QRS duration in response to OSA would 
produce a greater percentage change in women versus men, 
making it easier to detect statistically. On the other hand, there 
may be a true difference between men and women in response 
of the left ventricle to the afterload burden imposed by OSA. 
Animal studies have shown differences in gene expression be-
tween males and females in response to pressure overload.22 
In addition, women appear to have greater wall thickening in 
response to aortic stenosis than do men.23 Among hyperten-
sive patients followed by the LIFE study, women had reduced 
regression of electrocardiographic hypertrophy after 5 years 
of therapy versus men.24 Given these findings, it may be that 
women develop greater left ventricular hypertrophy in response 
to OSA, leading to greater QRS prolongation. Wall thickness 
tends to be slightly less in women than men; thus the female 
heart might experience greater wall stress from the high nega-
tive intrathoracic pressure produced by obstructive apneas.
Regarding the relationship between QT duration and OSA, 
previous studies have reported conflicting findings. Smith et 
al.25 measured QT and PR interval changes associated with 
spontaneous and respiratory-related arousals in OSA patients, 
finding a shortening of the QT during arousal. However, that 
study included only 20 OSA patients and lacked a control 
group. In another study, Lue et al.26 reported opposite find-
Table 5—Multivariate predictors for QRS duration stratified by sex
Predictor
Males
ß-Estimate (SE) p-value
Females
ß-Estimate (SE) p-value
Race -6.5369 (3.02) 0.0343 -1.3668 (1.94) 0.4840
Congestive heart failure 15.1239 (5.32) 0.0059 8.4250 (4.11) 0.0426
Atrial fibrillation 24.7257 (6.64) 0.0004 16.7225 (7.46) 0.0260
Apnea-hypopnea index -0.0257 (0.05) 0.6409 0.1055 (0.05) 0.0565
All variables listed in Table 1 were included in the model.
Table 4—Univariate predictors for QRS duration
Predictor ß-Estimate (SE) p-value
Gender (Female) -4.0230 (0.96) < 0.0001
Race -1.876 (0.97) 0.0600
Hypertension -1.7988 (0.98) 0.0700
Coronary artery disease -2.8586 (1.31) 0.0308
Congestive heart failure -6.1830 (1.65) 0.0002
Atrial fibrillation -11.5424 (2.44) < 0.0001
Apnea hypopnea index 0.0705 (0.03) 0.0540
All variables in Table 1 were analyzed. Significant predictors were 
considered if p-value ≤ 0.10.
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ings with prolongation of the QT and corrected QT intervals 
in the OSA group compared to controls. In our study, we did 
not find an association between OSA and QTc interval. These 
conflicting results might be explained by the multiple factors 
that influence QT duration, and the fact that it can change 
very rapidly.
Mechanistic Considerations
Prolonged QRS and OSA can each be seen in various car-
diovascular conditions with important clinical implications.1,2 
Both have been associated with increased left ventricle mass, 
hypertension,3 congestive heart failure,4 and ventricular ar-
rhythmias.27,28 Several pathophysiologic mechanisms can ex-
plain these associations. In OSA, breathing against a closed 
upper airway generates high negative intrathoracic pressure, 
which increases left ventricular transmural pressure and af-
terload, contributing to left ventricular hypertrophy.29 Further-
more, OSA is an accepted causal factor for the development 
of hypertension, which also contributes to left ventricular hy-
pertrophy. Other possible mechanisms by which OSA might 
contribute to QRS widening include endothelial dysfunc-
tion,29 systemic inflammation, sympathetic activation, blood 
pressure surges, and oxidative stress, all of which contribute 
to increased arterial stiffness9 and increased afterload stress 
on the left ventricle.
Strengths and Limitations
Our study has a large sample size in comparison with most 
OSA studies. All of our patients underwent polysomnography 
study, the gold standard test to define this condition; this al-
lowed us to assess OSA severity. We performed multivariate 
analyses to control for many of the clinical factors that could 
confound our results. Our study has some limitations. Given the 
cross-sectional nature of the study we cannot determine causal-
ity, as we cannot assess if prolonged QRS duration preceded 
or followed development of OSA. Our sample population was 
mainly African American, limiting generalizability of these 
results to other populations. In the multivariate analysis QRS 
prolongation was independently associated with OSA in wom-
en, but not in men, which could be due to overadjustment (ex-
ample: hypertension and obesity, conditions commonly found 
in OSA) or insufficient power, as the majority of our popula-
tion sample were women. Lead time bias is likely present in 
our study, as the onset of OSA in our population is not well 
established. However, in theory the longer the disease has been 
present, the greater the impact on cardiovascular disease, in our 
case the greater the QRS prolongation.
CONCLUSIONS
This is the first study linking increased QRS duration with 
OSA and may help explain the increased risk of sudden cardi-
ac death in both conditions. For the overall sample, increased 
QRS duration was significantly associated with OSA, partic-
ularly in those with severe OSA (AHI > 30). After multivari-
ate analyses severe OSA remained a significant independent 
predictor of prolonged QRS in women but not in men, while 
congestive heart failure and atrial fibrillation remained inde-
pendent predictors in both men and women. Nevertheless, 
prolongation of QRS duration in either sex may potentiate 
arrhythmic risk associated with OSA. Mechanisms underly-
ing the gender effects of the QRS-OSA interaction remain to 
be determined.
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